NYCB-A New York Community Bancorp Inc

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13D

 

Under the Securities Exchange Act of 1934

(Amendment No. 3)*

 

New York Community Bancorp, Inc.

(Name of Issuer)

Common Stock, par value $0.01 per share

(Title of Class of Securities)

649445400

(CUSIP Number)

William Barratt Liberty 77 Capital L.P. 2099 Pennsylvania Ave NW Washington, DC 20006 (202) 984-7070

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

September 20, 2024

(Date of Event which Requires Filing of this Statement)

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ¨

 

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Act”), or otherwise subject to the liabilities of Section 18 of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

CUSIP No. 649445400

SCHEDULE 13D

Page 2 of 14

 

 

1	NAME OF REPORTING PERSON   Liberty 77 Capital L.P.
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP	(a)  ☐ (b)  ☐
3	SEC USE ONLY
4	SOURCE OF FUNDS   OO
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)	☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION   Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	7	SOLE VOTING POWER   75,000,094
	8	SHARED VOTING POWER   0
	9	SOLE DISPOSITIVE POWER   75,000,094
	10	SHARED DISPOSITIVE POWER   0

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON   75,000,094
12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES	☐
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)   18.1%
14	TYPE OF REPORTING PERSON   IA, PN

 

 

 

CUSIP No. 649445400

SCHEDULE 13D

Page 3 of 14

 

 

1	NAME OF REPORTING PERSON   Liberty Strategic Capital (CEN) Holdings, LLC
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP	(a)  ☐ (b)  ☐
3	SEC USE ONLY
4	SOURCE OF FUNDS   OO
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)	☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION   Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	7	SOLE VOTING POWER   75,000,094
	8	SHARED VOTING POWER   0
	9	SOLE DISPOSITIVE POWER   75,000,094
	10	SHARED DISPOSITIVE POWER   0

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON   75,000,094
12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES	☐
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)   18.1%
14	TYPE OF REPORTING PERSON   OO

 

 

 

CUSIP No. 649445400

SCHEDULE 13D

Page 4 of 14

 

 

1	NAME OF REPORTING PERSON   Liberty 77 Capital Partners L.P.
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP	(a)  ☐ (b)  ☐
3	SEC USE ONLY
4	SOURCE OF FUNDS   OO
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)	☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION   Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	7	SOLE VOTING POWER   75,000,094
	8	SHARED VOTING POWER   0
	9	SOLE DISPOSITIVE POWER   75,000,094
	10	SHARED DISPOSITIVE POWER   0

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON   75,000,094
12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES	☐
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)   18.1%
14	TYPE OF REPORTING PERSON   PN

 

 

 

CUSIP No. 649445400

SCHEDULE 13D

Page 5 of 14

 

 

1	NAME OF REPORTING PERSON   Liberty Capital L.L.C.
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP	(a)  ☐ (b)  ☐
3	SEC USE ONLY
4	SOURCE OF FUNDS   OO
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)	☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION   Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	7	SOLE VOTING POWER   75,000,094
	8	SHARED VOTING POWER   0
	9	SOLE DISPOSITIVE POWER   75,000,094
	10	SHARED DISPOSITIVE POWER   0

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON   75,000,094
12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES	☐
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)   18.1%
14	TYPE OF REPORTING PERSON   OO

 

 

 

CUSIP No. 649445400

SCHEDULE 13D

Page 6 of 14

 

 

1	NAME OF REPORTING PERSON   STM Partners LLC
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP	(a)  ☐ (b)  ☐
3	SEC USE ONLY
4	SOURCE OF FUNDS   OO
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)	☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION   Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	7	SOLE VOTING POWER   75,000,094
	8	SHARED VOTING POWER   0
	9	SOLE DISPOSITIVE POWER   75,000,094
	10	SHARED DISPOSITIVE POWER   0

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON   75,000,094
12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES	☐
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)   18.1%
14	TYPE OF REPORTING PERSON   OO

 

 

 

CUSIP No. 649445400

SCHEDULE 13D

Page 7 of 14

 

 

1	NAME OF REPORTING PERSON   Steven T. Mnuchin
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP	(a)  ☐ (b)  ☐
3	SEC USE ONLY
4	SOURCE OF FUNDS   OO
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)	☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION   United States of America

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	7	SOLE VOTING POWER   75,000,094
	8	SHARED VOTING POWER   0
	9	SOLE DISPOSITIVE POWER   75,000,094
	10	SHARED DISPOSITIVE POWER   0

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON   75,000,094
12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES	☐
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)   18.1%
14	TYPE OF REPORTING PERSON   IN

 

 

 

CUSIP No. 649445400

SCHEDULE 13D

Page 8 of 14

 

 

This Amendment No. 3 amends and supplements the Schedule 13D, originally filed on March 14, 2024, as amended through the date hereof (as so amended, the “Schedule 13D”) and is being filed with the Securities and Exchange Commission (the “SEC”) by the “Reporting Persons” identified herein relating to the Common Stock, par value U.S. $0.01 per share (the “Common Stock”), of New York Community Bancorp, Inc., a Delaware corporation (the “Issuer”).

 

Item 2.

Identity and Background.

Item 2 is hereby restated as follows:

This Schedule 13D is being filed by each of:

(i)

Liberty 77 Capital L.P. (the “Liberty Manager”), a Delaware limited partnership which is investment manager of the Liberty Funds (defined in Item 5(d) below) and manager of the Liberty Purchaser;

(ii)

Liberty Strategic Capital (CEN) Holdings, LLC (the “Liberty Purchaser”), a Delaware limited liability company;

(iii)

Liberty 77 Capital Partners L.P. (“Liberty Manager GP”), a Delaware limited partnership and the general partner of the Liberty Manager;

(iv)

Liberty Capital L.L.C., a Delaware limited liability company and the general partner of the Liberty Manager GP;

(v)

STM Partners LLC, a Delaware limited liability company which indirectly controls the Liberty Manager and the Liberty Purchaser;

(vi)

Steven T. Mnuchin (“Secretary Mnuchin”), an individual and citizen of the United States and president of STM Partners LLC,

each person or entity listed in clauses (i) – (vi), a “Reporting Person” and, collectively, the “Reporting Persons.”

The address of the principal place of business and principal office of the Reporting Persons is c/o Liberty 77 Capital L.P., 2099 Pennsylvania Avenue NW, Washington, D.C. 20006.

The Reporting Persons are making this single, joint filing, pursuant to a joint filing agreement in accordance with Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which is filed as Exhibit 1 hereto.

None of the Reporting Persons has, during the last five years, (i) been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors), or (ii) been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding were or are subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

Item 4.

Purpose of Transaction.

Item 4 is hereby restated as follows:

 

On March 7, 2024, the Issuer entered into an Investment Agreement (the “Original Investment Agreement”) with the Liberty Purchaser. On March 11, 2024, the Issuer entered into an amendment to the Liberty Investment Agreement with the Liberty Purchaser (as the “Amendment”, and the Original Investment as amended by the Amendment, the “Liberty Investment Agreement”).

 

CUSIP No. 649445400

SCHEDULE 13D

Page 9 of 14

 

 

Pursuant to the Liberty Investment Agreement, on the terms and subject to the conditions set forth therein, at the closing of the Liberty Purchaser’s investment in the Issuer on March 11, 2024 (the “Closing”), the Liberty Purchaser invested an aggregate of approximately $450 million in exchange for the Issuer’s sale and issuance of: (a) 34,940,000 shares of Common Stock at a purchase price of $2.00; (b) 143,355 shares of a new series of preferred stock, par value $0.01 per share, of the Issuer designated as Series B Noncumulative Convertible Preferred Stock (the “Series B Preferred Stock”), at a price per share of $2,000 and each of which is automatically convertible into 1,000 shares of Common Stock in the event of a transfer thereof by the Liberty Purchaser consistent with the rules and limitations of Regulation Y of the Bank Holding Company Act of 1956, as amended (the “BHCA”), subject to certain limitations (a “Reg Y Transfer”), and which shares of Series B Preferred Stock collectively represented the right (on an as-exchanged basis) to receive approximately 143,355,000 shares of Common Stock (subject to certain adjustments, including adjustments relating to the Reverse Stock Split (as defined below)); (c) 46,705 shares of a new series of preferred stock, par value $0.01 per share, of the Issuer designated as Series C Noncumulative Convertible Preferred Stock (the “Series C Preferred Stock”, together with the Series B Preferred Stock, the “Preferred Stock”), at a price per share of $2,000 and each of which was (i) convertible prior to the receipt of the Requisite Stockholder Approvals (as defined below) at the option of the Liberty Purchaser into 1,000 shares Common Stock up to a limit of 22% of total shares of Series C Preferred Stock held at the Closing and (ii) automatically convertible into 1,000 shares of Common Stock upon the occurrence of certain events (including (i) a portion upon the expiration or termination of any applicable waiting period (or extension thereof) under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), with respect to the Liberty Purchaser’s acquisition or ownership of Common Stock and (ii) the remaining portion upon receipt of the Requisite Stockholder Approvals (as defined below) and all of which shares of Series C Preferred Stock represented the right (on an as-converted basis) to receive approximately 46,705,000 shares of Common Stock; and (d) net-settled warrants (the “Issued Warrants”), which were not exercisable for 180 days after the Closing, affording the Liberty Purchaser the right, until the seven-year anniversary of the issuance of such warrant, to purchase for $2,500 per share, shares of a new class of non-voting, common-equivalent preferred stock of the Issuer (the “Series D NVCE Stock”), each share of which is convertible into 1,000 shares of Common Stock (or, in certain limited circumstances, one share of Series C Preferred Stock) in a Reg Y Transfer, and all of which shares of Series D NVCE Stock, upon issuance, would represent the right (on an as-converted basis) to receive 135,000,000 shares of Common Stock (clauses (a) through (d), collectively referred to herein as the “Investment”).

 

On July 11, 2024, the Issuer effected a one-for-three reverse stock split (the “Reverse Stock Split”) as approved by the Issuer’s shareholders at its annual meeting on June 5, 2024 (the “2024 Annual Meeting”). As a result, every three shares of Common Stock issued and outstanding were automatically exchanged into one new share of Common Stock. Accordingly, the securities listed on the cover pages of this amended Schedule 13D reflect the Reverse Stock Split, including the effects of the Reverse Stock Split on the conversion ratios described above.

Requisite Stockholder Approvals

In connection with the Investment, the Issuer submitted to its stockholders for their (a) adoption and approval amendments to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) to: (i) effect a one-for-three reverse stock split of Common Stock (the “COI Reverse Stock Split Amendment”); (ii) increase the number of authorized shares of the Common Stock to 2,000,000,000 (the “COI Authorized Share Amendment”); and (iii) exempt the Liberty Purchaser and certain other investors and their respective affiliates from the application of a provision of the Certificate of Incorporation that prohibits any person who beneficially owns, directly or indirectly, more than 10% of the then-outstanding shares of Common Stock from voting any such shares of Common Stock in excess of such 10% threshold (the “COI Exemption Amendment” and, collectively with the COI Reverse Stock Split Amendment and the COI Authorized Share Amendment, the “COI Amendments”); and (b) approval of the issuance of shares of Common Stock that have 20% or more of the pre-issuance total voting power of the Issuer’s securities (the “Share Issuance”) in accordance with the rules of the New York Stock Exchange (the “NYSE”).

 

 

CUSIP No. 649445400

SCHEDULE 13D

Page 10 of 14

 

 

The requisite vote of the Issuer’s stockholders necessary to duly and validly (a) adopt and approve the COI Authorized Share Amendment required the affirmative vote of a majority of votes cast by the holders of shares of Common Stock, at a duly held meeting of the Issuer’s stockholders, (b) adopt and approve the COI Exemption Amendment required the affirmative vote of the holders of a majority of the outstanding shares of Common Stock entitled to vote on the COI Exemption Amendment and (c) approve the Share Issuance required the affirmative vote of a majority of votes cast by holders of shares of Common Stock at a duly convened meeting of stockholders of the Issuer at which a quorum is present (collectively, the “Requisite Stockholder Approvals”). The Requisite Stockholder Approvals were obtained during the 2024 Annual Meeting.

 

Additional Liberty Rights and Covenants

In addition, pursuant to the Liberty Investment Agreement, the Liberty Purchaser agreed not to convert more than 6,751 shares of Series C Preferred Stock prior to receipt of the Requisite Stockholder Approvals. On March 13, 2024, the Liberty Purchaser instructed the Issuer to effect the conversion of 6,751 shares of Series C Preferred Stock into 6,751,000 shares of Common Stock. Subsequently, after receipt of the Requisite Stockholder Approvals, the Liberty Purchaser’s remaining 39,954 shares of Series C Preferred Stock were automatically converted into 39,954,000 shares of Common Stock.

Additionally, under the Liberty Investment Agreement, after receipt of antitrust clearance under the HSR Act and the Requisite Stockholder Approvals, the Liberty Purchaser had the right to exchange a certain amount of its shares of Series B Preferred Stock into Common Stock in a manner that complied with applicable banking laws and regulations, including the rules and limitations of Regulation Y of the BHCA, or with the terms of any non-objection received by the Federal Reserve Board under the Change in Bank Control Act of 1978 (as amended). On August 12, 2024, the Liberty Purchaser and the Issuer completed a partial exchange of the Liberty Purchaser’s shares of Series B Preferred Stock pursuant to which 29,000 shares of Series B Preferred Stock were exchanged for 9,666,665 shares of Common Stock in accordance with the terms of the Liberty Investment Agreement and the related certificate of designations for the Series B Preferred Stock. Following receipt by the Reporting Persons of the Federal Reserve Board’s non-objection on September 20, 2024, on September 23, 2024, the Liberty Purchaser and the Issuer completed the exchange of the Liberty Purchaser’s remaining shares of Series B Preferred Stock pursuant to which 114,355 shares of Series B Preferred Stock were exchanged for 38,118,329 shares of Common Stock in accordance with the terms of the Liberty Investment Agreement and the related certificate of designations for the Series B Preferred Stock.

Under the terms of the Liberty Investment Agreement, upon the Closing the Liberty Purchaser also became entitled to nominate two representatives to be elected to the Issuer’s Board of Directors (the “NYCB Board”), subject to (a) the receipt by the Liberty Purchaser of certain regulatory approvals, consents or non-objections and the completion of any applicable waiting periods and (b) satisfaction of certain eligibility requirements (collectively, “Eligibility Requirements”), so long as the Liberty Purchaser and its affiliates beneficially own at least the lesser of (i) 2.5% of the outstanding shares of Common Stock (on an as-converted basis) or (ii) 25% of the shares of Common Stock (on an as-converted basis) that the Liberty Purchaser beneficially owned immediately following the Closing. As of the date hereof, the Liberty Purchaser has appointed one director representative, Secretary Mnuchin, to the NYCB Board.

Pursuant to the Liberty Investment Agreement, each of the Issuer and the Liberty Purchaser agreed to indemnify the other and their respective affiliates from and against all losses (subject to certain exceptions) directly resulting from (a) any inaccuracy in or breach of any representation or warranty of such party set forth in the Liberty Investment Agreement or (b) such party’s breach of any of its agreements or covenants in the Liberty Investment Agreement, in each case, subject certain limitations.

 

 

CUSIP No. 649445400

SCHEDULE 13D

Page 11 of 14

 

 

The securities listed on the cover pages of this amended Schedule 13D also reflect 100 service-based restricted stock units (after adjustment for the Reverse Stock Split) that were granted to Steven T. Mnuchin on March 27, 2024 in connection with his service as a director of the Issuer. The restricted stock units will vest over the passage of time in shares of Common Stock.

Registration Rights Agreement

On March 11, 2024, the Issuer entered into a Registration Rights Agreement with the Liberty Purchaser and certain other investors (the “Registration Rights Agreement”), pursuant to which the Issuer will provide customary registration rights to the Liberty Purchaser and its affiliates and certain permitted transferees with respect to (a) the shares of Common Stock purchased under the Liberty Investment Agreement, (b) shares of Common Stock issued upon the conversion of shares of the Preferred Stock and exercise of the Issued Warrants purchased under the Liberty Investment Agreement and (c) the Issued Warrants (as defined below). Under the Registration Rights Agreement, the Investors are entitled to customary shelf registration rights (which will initially be on a Form S-1, after which the Issuer will use commercially reasonable efforts to promptly convert the shelf registration statement on Form S-1 into a shelf registration statement on Form S-3, subject to certain limitations as set forth in the Registration Rights Agreement) and customary piggyback registration rights, in each case, subject to certain limitations as set forth in the Registration Rights Agreement. The Liberty Purchaser and another investor will additionally be entitled to request a certain number of marketed and unmarketed underwritten shelf takedowns and shall have the right to select the managing underwriter to administer any underwritten shelf takedowns provided the selection is reasonably acceptable to the Issuer.

On June 21, 2024, the Issuer filed a registration statement on Form S-1 along with a preliminary prospectus, later amended on August 23, 2024, in each case relating to the registration of the securities that are the subject of the Registration Rights Agreement.

 

Issued Warrants

 

On March 11, 2024, pursuant to the Liberty Investment Agreement, the Issuer issued the Issued Warrants to the Liberty Purchaser to purchase (in the aggregate) approximately 135,000 shares of Series D NVCE Stock (subject to certain adjustments, including adjustments relating to the Reverse Stock Split), each at an exercise price of $2,500 per share, subject to customary anti-dilution adjustments provided under the Issued Warrants. On and following September 10, 2024, and prior to 5:00pm (New York City time) on March 11, 2031, the Issued Warrants may be exercised, on a net share settlement basis, by the Liberty Purchaser.

 

Exhibits

The foregoing descriptions of the Liberty Investment Agreement (including the terms of the Preferred Stock, the Series D NVCE Stock and the Issued Warrants) and the Registration Rights Agreement (collectively, the “Transaction Agreements”) and the transactions contemplated thereby are not complete and are subject to and qualified in their entirety by reference to the full text of such agreements, copies of which are attached to this Schedule 13D as Exhibit 2 and Exhibit 3, respectively, and are incorporated herein by reference.

 

 

CUSIP No. 649445400

SCHEDULE 13D

Page 12 of 14

 

 

General

The Reporting Persons have acquired the securities reported in this Schedule 13D for investment purposes and intend to review such investment in the Issuer on a continuing basis. As such, the Reporting Persons may, depending on the Issuer’s performance and other market conditions, increase or decrease their investment position. The Reporting Persons may, from time to time, make additional purchases of Common Stock or other securities of the Issuer either in the open market or in privately negotiated transactions, depending upon their evaluation of the Issuer’s business, prospects, financial condition and results of operations, the market for the Common Stock or other securities, other opportunities available to the Reporting Persons, general economic conditions, stock market conditions and other factors. Depending upon the factors noted above, the Reporting Persons may also decide to hold or dispose of all or part of their investments in the Common Stock and/or enter into derivative transactions with institutional counterparties with respect to the Issuer’s securities, including the Common Stock. Any actions the Reporting Persons might undertake may be made at any time, and from time to time, without prior notice, and will be dependent upon their review of numerous factors, including but not limited to, an ongoing evaluation of the Issuer’s business, financial condition, operations and prospects; price levels of the Issuer’s securities; general market, industry and economic conditions; the relative attractiveness of alternative business and investment opportunities; and other future developments.

Consistent with the Reporting Persons’ investment purposes and, in addition to their governance rights described above, they may engage in communications with, without limitation, one or more stockholders of the Issuer, management of the Issuer and/or one or more members of the Issuer’s board of directors and may make suggestions concerning the Issuer’s operations, prospects, business and financial strategies, strategic transactions, assets and liabilities, business and financing alternatives, dividend policy, the composition of the Issuer’s board of directors and such other matters as the Reporting Persons may deem relevant to their investment in the Issuer.

Item 5.

Interest in Securities of the Issuer.

Item 5 is hereby restated as follows:

See Item 4 and the cover page for each Reporting Person, which are incorporated by reference herein.

References to percentage ownership of the Common Stock in this Schedule 13D are based on 415,261,212 shares of Common Stock (and 415,261,312 shares of Common Stock after giving effect to the 100 service-based restricted stock units (after adjustment for the Reverse Stock Split) that were granted to Steven T. Mnuchin on March 27, 2024, as described herein) outstanding as of the close of business on September 23, 2024 after giving effect to the exchange of the Series B Preferred Stock as described herein (including the issuance of 38,118,329 shares of Common Stock to the Liberty Purchaser upon the final exchange of its Series B Preferred Stock), based on the information reported by the Issuer in its Current Report on Form 8-K, dated September 24, 2024.

(a) and (b)

As of the date of this Schedule 13D, the Reporting Persons are deemed to beneficially own 75,000,094 shares of Common Stock (representing approximately 18.1% of the Common Stock), of which 74,999,994 shares of Common Stock are held directly by the Liberty Purchaser and 100 service-based restricted stock units (after adjustment for the Reverse Stock Split) were granted to Steven T. Mnuchin on March 27, 2024, and may be deemed to be indirectly beneficially owned by the other Reporting Persons.

(c) Except as described in this Schedule 13D, there have been no transactions in the Common Stock effected by the Reporting Persons since the most recent prior amendment to this Schedule 13D.

(d) Liberty 77 Fund L.P. and Liberty 77 Fund International L.P. (the “Liberty Funds”) are the members of the Liberty Purchaser and, as such, have the right to receive dividends from, or the proceeds from the sale of, the securities that are reported in this Schedule 13D. Liberty 77 Capital GenPar L.P. is the general partner of each of the Liberty Funds. Liberty 77 Capital UGP L.L.C. is the general partner of Liberty 77 Capital GenPar L.P. STM Partners LLC is the managing member of Liberty 77 Capital UGP L.L.C.

(e) Not applicable.

 

CUSIP No. 649445400

SCHEDULE 13D

Page 13 of 14

 

 

SIGNATURES

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Date: September 24, 2024

 

	LIBERTY 77 CAPITAL L.P.
	By:	Liberty 77 Capital Partners L.P., its general partner
	By:	Liberty Capital L.L.C., its general partner
	By:	/s/ Jesse M. Burwell
	Name:	Jesse M. Burwell
	Title:	Chief Financial Officer
	LIBERTY STRATEGIC CAPITAL (CEN) HOLDINGS, LLC
	By:	Liberty 77 Capital L.P., its manager
	By:	Liberty 77 Capital Partners L.P., its general partner
	By:	Liberty Capital L.L.C.,
		its general partner
	By:	/s/ Jesse M. Burwell
	Name:	Jesse M. Burwell
	Title:	Chief Financial Officer
	LIBERTY 77 CAPITAL PARTNERS L.P.
	By:	Liberty Capital L.L.C., its general partner
	By:	/s/ Jesse M. Burwell
	Name:	Jesse M. Burwell
	Title:	Chief Financial Officer

 

 

 

CUSIP No. 649445400

SCHEDULE 13D

Page 14 of 14

 

 

	LIBERTY CAPITAL L.L.C.
	By:	/s/ Jesse M. Burwell
	Name:	Jesse M. Burwell
	Title:	Chief Financial Officer

 

	STM PARTNERS LLC
	By:	/s/ Jesse M. Burwell
	Name:	Jesse M. Burwell as attorney-in-fact for Steven T. Mnuchin
	Title:	President
	/s/ Jesse M. Burwell
	Jesse M. Burwell as Attorney-in-Fact for Steven T. Mnuchin

 

 

 

 

---